- Home
- SOWG vs IXHL Comparison
SOWG vs IXHL Comparison
Compare SOWG & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOWG
- IXHL
- Stock Information
- Founded
- SOWG 2010
- IXHL 2001
- Country
- SOWG United States
- IXHL Australia
- Employees
- SOWG N/A
- IXHL N/A
- Industry
- SOWG Packaged Foods
- IXHL
- Sector
- SOWG Consumer Staples
- IXHL
- Exchange
- SOWG Nasdaq
- IXHL Nasdaq
- Market Cap
- SOWG 22.6M
- IXHL 22.7M
- IPO Year
- SOWG N/A
- IXHL N/A
- Fundamental
- Price
- SOWG $2.43
- IXHL $0.75
- Analyst Decision
- SOWG Strong Buy
- IXHL
- Analyst Count
- SOWG 2
- IXHL 0
- Target Price
- SOWG $23.00
- IXHL N/A
- AVG Volume (30 Days)
- SOWG 33.8K
- IXHL 49.1K
- Earning Date
- SOWG 03-21-2025
- IXHL 02-14-2025
- Dividend Yield
- SOWG N/A
- IXHL N/A
- EPS Growth
- SOWG N/A
- IXHL N/A
- EPS
- SOWG 0.21
- IXHL N/A
- Revenue
- SOWG $40,130,971.00
- IXHL $98,000.00
- Revenue This Year
- SOWG $122.17
- IXHL $3,817.06
- Revenue Next Year
- SOWG N/A
- IXHL $66.67
- P/E Ratio
- SOWG $11.63
- IXHL N/A
- Revenue Growth
- SOWG 508.45
- IXHL N/A
- 52 Week Low
- SOWG $1.98
- IXHL $0.73
- 52 Week High
- SOWG $24.83
- IXHL $3.84
- Technical
- Relative Strength Index (RSI)
- SOWG 46.21
- IXHL 19.57
- Support Level
- SOWG $2.20
- IXHL $0.73
- Resistance Level
- SOWG $2.36
- IXHL $1.88
- Average True Range (ATR)
- SOWG 0.19
- IXHL 0.11
- MACD
- SOWG 0.01
- IXHL -0.06
- Stochastic Oscillator
- SOWG 47.13
- IXHL 2.38
About SOWG Sow Good Inc. Common Stock
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free granola products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.